Centrillion Technologies Listed by cicada3301 Ransomware Group: Ransomware Claim — What’s Alleged & What To Do

Ransomware groups continue to target specialized technology and life-sciences firms, using double-extortion tactics that combine network encryption with data theft and public leak-site pressure. Listings of this kind have become a routine feature of the current threat landscape, often appearing before any independent confirmation of impact.

On 11 October 2024 Centrillion Technologies was listed by the ransomware group cicada3301. The group claims that internal files were exfiltrated during a ransomware attack and has threatened to publish the material if the company does not make contact. The number of people affected remains unknown and further technical details have not been publicly confirmed.

Breaking down the breach

Public reporting of the incident is limited to the leak-site listing dated 11 October 2024. According to that listing, cicada3301 asserts that it conducted a ransomware attack against Centrillion Technologies and removed internal files. The group’s own statement includes the warning that the data will be published if the company does not contact them soon. No independent verification of the intrusion method, the volume of data taken, the systems affected, or the precise timeline has been released. The number of individuals whose information may be involved is listed as unknown. Beyond the group’s claim of exfiltrated internal files, no further technical indicators or forensic findings have been disclosed.

The group behind it: cicada3301

cicada3301 is a ransomware operation that follows the now-standard double-extortion model: operators gain access to a network, deploy encryption malware, exfiltrate data, and then post the victim’s name on a dedicated leak site to increase pressure for payment. Publicly documented activity by the group shows a pattern of listing organisations across multiple sectors, often accompanied by countdown-style threats or demands for contact. The group typically claims responsibility for both the encryption event and the theft of files, using the threat of publication as leverage. In this instance the listing of Centrillion Technologies is presented solely as the group’s own claim; no confirmation from the company or from independent investigators has been made public.

Centrillion Technologies and its sector

Centrillion Technologies develops next-generation DNA chips that use in-situ synthesis to produce large numbers of distinct DNA sensors on a single wafer. The company was founded to advance these chips and their applications in genomics and related fields. Organisations working in this specialised biotech and molecular-diagnostics space routinely handle proprietary research data, intellectual property covering chip design and synthesis methods, laboratory protocols, supplier and partner information, and internal corporate records. A breach affecting such an organisation can therefore expose both commercial secrets and any personal or contractual data that may be stored alongside research materials, with potential consequences for ongoing scientific programmes and competitive position.

The information in question

The only data type named in the available facts is “internal files” said to have been exfiltrated in a ransomware attack. Exact contents, file volumes, and whether any personal identifiers, research datasets, or customer records were included remain undisclosed. Companies of this type typically maintain design files, experimental results, employee records, contracts, and intellectual-property documentation. Because the precise inventory has not been confirmed, it is not possible to state what specific categories of information were taken.

Why it matters

For individuals whose details may appear among the internal files, the principal risks include potential misuse of contact or employment information and the longer-term possibility of targeted phishing that references the organisation. For Centrillion Technologies the exposure of proprietary DNA-chip designs or research data could undermine competitive advantage, delay product development, and create regulatory or contractual obligations to notify partners. Even when the scale of impact is unknown, the mere public listing can erode trust among collaborators and investors in a sector that depends on confidentiality of scientific assets. Until more detail emerges, both the organisation and any potentially affected parties must treat the claim as an unresolved risk rather than a fully quantified event.

What to do if you're exposed

If you have a past or present connection to Centrillion Technologies—whether as an employee, contractor, research partner or supplier—consider the following practical steps:

• Monitor financial and email accounts for unusual activity and enable multi-factor authentication where available.
• Change passwords on any accounts that may have used the same credentials associated with the organisation.
• Review credit reports or place fraud alerts if you believe personal identifiers could have been involved.
• Remain alert to phishing messages that reference DNA technology, Centrillion, or related research topics.
• Run a free exposure scan of your email address to check whether it has already appeared in known breach datasets.

Public detail remains limited; further official statements from the company or law-enforcement agencies will provide the most reliable updates. In the meantime, treating the listing as a credible but unconfirmed claim allows measured rather than alarmist responses.

AICompiled with AI assistance from public sources and published under our editorial standards.